Patent directory · USPTO A61K / A61P
Patents matching “therapy”
782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11660330
Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy
granted -
US 11654145
Combination therapy involving diaryl macrocyclic compounds
granted -
US 11655455
Enhanced systems for cell-mediated oncolytic viral therapy
granted -
US 11648307
Anti-DC-HIL antibodies for cancer diagnosis, prognosis and therapy
granted -
US 11648302
Indoleamine 2,3-dioxygenase based immunotherapy
granted -
US 11642366
Methods for preventing a serious health consequence and/or tissue damage after exposure to ionizing radiation and/or chemotherapy
granted -
US 11642374
Intracellular genomic transplant and methods of therapy
granted -
US 11642375
Intracellular genomic transplant and methods of therapy
granted -
US 11642401
Activation of resident memory T cells for cancer immunotherapy
granted -
US 11640848
Immunotherapy methods for patients whose tumors carry a high passenger gene mutation burden
granted -
US 11638753
Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy
granted -
US 11631483
Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
granted -
US 11618784
Anti-CD47 combination therapy
granted -
US 11612652
Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy
granted -
US 11607557
Devices and systems for treating pain based on light therapy
granted -
US 11608367
Peptides for angiogenic therapy
granted -
US 11596694
Compositions and methods for predicting response to NaPi2b-targeted therapy
granted -
US 11596671
Gene therapy of hemophilia B using viral vectors encoding recombinant fix variants with increased expression
granted -
US 11596696
Combination therapy with an anti-CD25 antibody-drug conjugate
granted -
US 11591402
Neutralizing antibodies to the alpha v beta 8 integrin complex for immunotherapy
granted -
US 11591579
Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy
granted -
US 11583556
Modified cells and methods of therapy
granted -
US 11576883
L-DOPA microbiome therapy
granted -
US 11578371
Biomarkers for predicting tumor response to and toxicity of immunotherapy
granted